CDKN2A and cancer: However, Chen et al. noted that in cancer cells ULF mediating p14/ARF degradation was abrogated due to the commonly overexpressed nucleophosmin (NPM) and c-Myc, which made the degradation of p14/ARF in cancer cells remain elusive [49, 50].